-
Omnicell (OMCL) Reiterated at Buy by Benchmark After Investor, CFO Meet
-
Omnicell (OMCL) Reiterated at Buy by Benchmark After Investor, CEO Meet
-
Omnicell (OMCL) Misses Q4 EPS by 10c, Beats on Revenue; Offers FY26 Guidance
-
BofA Securities Upgrades Omnicell (OMCL) to Buy
-
Omnicell (OMCL) PT Raised to $60 at Benchmark on Optimistic Outlook
-
Omnicell (OMCL) PT Raised to $53 at BofA Securities
-
KeyBanc Upgrades Omnicell (OMCL) to Overweight
-
Allegro MicroSystems, Inc. (ALGM) Wells Fargo 14 High-Conviction 2026 Ideas
-
Omnicell (OMCL) PT Raised to $46 at BofA Securities
-
Omnicell (OMCL) PT Raised to $50 at Benchmark
-
Omnicell launches Titan XT automated medication dispensing system
-
Omnicell earns URAC certification for specialty pharmacy services
-
Omnicell (OMCL) Tops Q3 EPS by 15c ; Offers Guidance
-
Supreme court ruling against Trump's tariffs could propel this stock higher: WF
-
Evoke Pharma expands GIMOTI access through Omnicell partnership
-
KeyBanc Reiterates Sector Weight Rating on Omnicell (OMCL)
-
Omnicell (OMCL) PT Lowered to $55 at Piper Sandler Despite Guide Raise
-
Omnicell (OMCL) Tops Q2 EPS by 18c ; Offers Guidance
-
Omnicell (OMCL) PT Raised to $40 at Wells Fargo
-
Benchmark Reiterates Buy Rating on Omnicell (OMCL)
-
Craig-Hallum on Omnicell (OMCL): 'Current Valuation Makes For A Compelling Risk/Reward Situation.'
-
Benchmark Reiterates Buy Rating on Omnicell (OMCL)
-
Omnicell (OMCL) PT Raised to $34 at BofA Securities
-
Omnicell (OMCL) Announces New Products for Perioperative and Clinic Settings
-
Omnicell (OMCL) PT Lowered to $40 at Benchmark
-
Omnicell (OMCL) Tops Q1 EPS by 5c ; Offers Guidance
-
Omnicell (OMCL) appoints Perry Genova as CTO
-
Omnicell (OMCL) PT Lowered to $38 at BofA Securities
-
Omnicell (OMCL) announces CFO Etta stepping down
-
Omnicell (OMCL) Tops Q4 EPS by 2c ; Offers Guidance
-
Benchmark Reiterates Buy Rating on Omnicell (OMCL)
-
Omnicell (OMCL) PT Raised to $44 at JPMorgan
-
Omnicell (OMCL) Prices $150M Convertible Senior Notes Offering
-
Omnicell (OMCL) Announces Proposed Private Placement of $150 Million of Convertible Senior Notes
-
Omnicell (OMCL) PT Lowered to $54 at BofA Securities
-
BofA Securities Downgrades Omnicell (OMCL) to Neutral
-
Omnicell (OMCL) Tops Q3 EPS by 14c ; Offers Guidance
-
Benchmark Reiterates Buy Rating on Omnicell (OMCL)
-
Omnicell (OMCL) Appoints Nnamdi Njoku as COO
-
KeyBanc Reiterates Sector Weight Rating on Omnicell (OMCL)
-
Omnicell (OMCL) Announces Central Med Automation Service
-
Omnicell (OMCL) PT Raised to $61 at Piper Sandler
-
Barclays Upgrades Omnicell (OMCL) to Equalweight
-
Omnicell (OMCL) Tops Q2 EPS by 37c ; Offers Guidance

